Effect of Upper Extremity Rehabilitation Using Immersive Virtual Reality in Chronic Stroke Patients.
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Nov 23, 2021
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how virtual reality exercises can help improve the movement and function of the arms in people who have had a stroke. The researchers are specifically looking at patients who have been living with the effects of a stroke for at least six months and have some ability to move their arms, but may still struggle with everyday tasks. The goal is to see if using fun, interactive games in a virtual reality setting can support their recovery and make therapy more engaging.
To be eligible for this study, participants should be adults who have had a stroke that affects their upper body movement, but they need to be able to move their arms against gravity. People who have serious cognitive issues, other medical conditions affecting their arms, or a history of certain health problems may not be able to join. Those who do participate can expect to take part in virtual reality sessions designed to help strengthen their arm muscles and improve their daily activities. The study is currently looking for participants, so if you or someone you know fits the criteria, it could be a great opportunity to gain new therapeutic support.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chronic stroke patients who have passed 6 months or more without additional stroke after the first stroke
- • Patients with upper extremity dysfunction due to stroke (ischemic, hemorrhagic)
- • Patients who can move the upper extremity against gravity with a manual muscle test of grade 3 or higher in the affected shoulder and elbow, respectively
- • Patients who can stably maintain a sitting position
- • Patients who voluntarily agreed to participate in the study
- Exclusion Criteria:
- • Patients with moderate or severe cognitive impairment with a score of 18 or less on the Mini-Mental Status Examination (K-MMSE)
- • Patients with other causes of upper extremity dysfunction, such as peripheral nerve damage, joint disease, etc.
- • Patients with a history of severe vertigo or epilepsy
- • Patients with medical reasons such as medical conditions that make it difficult to participate in research
- • Patients who may be pregnant or who are pregnant or lactating
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
Incheon, , Korea, Republic Of
Seoul, , Korea, Republic Of
Yangpyeong, Gyeonggi Do, Korea, Republic Of
Patients applied
Trial Officials
Han Gil Seo, MD, PhD
Principal Investigator
Seoul National University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials